Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.40 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2980661 | 0.93 | FAAH (0.37) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL4438252 | 0.93 | FAAH (0.37) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL2982468 | 0.93 | FAAH (0.37) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL12120695 | 0.93 | LMNA (0.41) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL4912336 | 0.90 | FAAH (0.41) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL14244876 | 0.90 | SOAT1 (0.39) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL8358144 | 0.90 | FAAH (0.38) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL10666652 | 0.89 | FAAH (0.38) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL6898168 | 0.89 | CTSK (0.40) | FAAHCHRM1CHRM3AKR1A1HTR2A | |
| SCHEMBL6896725 | 0.89 | FAAH (0.35) | FAAHCHRM1CHRM3AKR1A1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12636476-B2 | Method of implantation of cell aggregates and tissue fragments | NEURONANO AB (SE) | 2026-05-26 | — | — | US | claimed |
| EP-3452124-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-10-08 | — | — | EP | claimed |
| EP-3452123-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-09-24 | — | — | EP | claimed |
| EP-3452126-B1 | HEMOSTATIC DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-08-27 | — | — | EP | claimed |
| EP-3452125-B1 | CUSTOMIZABLE ANCHORAGE DEVICES AND METHODS OF USE | MEDTRONIC INC (US) | 2025-07-16 | — | — | EP | claimed |
| CN-120073072-A | Azasilane electrolyte additive, electrolyte and lithium ion battery | 蓝固(淄博)新能源科技有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119912617-A | Copolymer microsphere and preparation method thereof | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119695271-A | Lithium ion battery electrolyte and application thereof | 徐州纳烯新材料研究院有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119627237-A | Electrolyte, secondary battery and electricity utilization device | 欣旺达动力科技股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119601761-A | Gel type lithium ion battery | 华彩(合肥)新能源科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| EP-0687697-B1 | A carbonate group-modified epoxy resin and thermosetting compositions of resins containing hydroxyalkyl carbonate groups | DAICEL CHEM (JP) | 2000-05-03 | — | — | EP | claimed |
| EP-0905217-A1 | Unleaded gasoline for direct injection gasoline engine | NIPPON OIL CO. LTD. (JP) | 1999-03-31 | — | — | EP | claimed |
| US-5705641-A | Process for the preparation of 1,3,5-triazine carbamates from amino-1,3,5-triazines and organic carbonates | CYTEC TECHNOLOGY CORP. (US) | 1998-01-06 | — | — | US | claimed |
| US-5556927-A | FILMS, COATINGS, REACTION OF EPOXY RESIN OR LACTONE MODIFIED EPOXY RESIN WITH CYCLIC CARBONATE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1996-09-17 | — | — | US | claimed |
| US-5486593-A | Medical devices fabricated from copolymers having recurring carbonate units | UNITED STATES SURGICAL CORPORATION (US) | 1996-01-23 | — | — | US | claimed |
| EP-0687697-A2 | A carbonate group-modified epoxy resin and thermosetting compositions of resins containing hydroxyalkyl carbonate groups | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-12-20 | — | — | EP | claimed |
| EP-0682054-A2 | A biodegradable copolymer, a biodegradable polymer composition, a biodegradable article, and a preparation process thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-11-15 | — | — | EP | claimed |
| US-5412068-A | Medical devices fabricated from homopolymers and copolymers having recurring carbonate units | UNITED STATES SURGICAL CORPORATION (US) | 1995-05-02 | — | — | US | claimed |
| US-5152781-A | Bioresorbable and biodurable polycarbonate biopolymers | ALLIED-SIGNAL INC. (US) | 1992-10-06 | — | — | US | claimed |
| US-5145945-A | Biocompatable | ALLIED-SIGNAL INC. (US) | 1992-09-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12636476-B2 | Method of implantation of cell aggregates and tissue fragments | ILK, CD44, CAPG | FAAH 4295/4885CHRM1 3148/4885CHRM3 2337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.